Thursday, November 14, 2024
Home 2023

Yearly Archives: 2023

Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review
2023 Watch List

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

Editor / Curator -
DarioHealth,
2023 Watch List

Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5...

Editor / Curator -
SEKER, INTERNETSTOCKREVIEW
AI Artificial Intelligence

NYC Woman says she Lost Over $740K After her Lawyer’s Email...

Editor / Curator -
AI Artificial Intelligence

Sekur (SWISF) Advances as Secure Communications Become Vital Against Breaches and...

Editor / Curator -
NTTS

The Weekly Hack with Alain Ghiai, Internet Privacy Expert.

Editor / Curator -
NTTS

New to the Street | Newsmax TV | Episode 503

Editor / Curator -
Biotech News

Ranked: The Most Popular Drugs in the U.S.

Editor / Curator -
2023 Watch List

Adding Dario Health (DRIO) $2.81 to Watch List.

Editor / Curator -
2023 Watch List

With Help of Sanofi (SNY), Dario Health (DRIO) Builds Scientific Case...

Editor / Curator -
All News

Pressure BioSciences, (PBIO) $0.28 Provides Business Update, and Offers Guidance for...

Editor / Curator -
1...8910...18Page 9 of 18

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.